Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases

Despite structural similarity, the five subtypes comprising the cholinergic muscarinic family of G protein-coupled receptors regulate remarkably diverse biological functions. This mini review focuses on the closely related and commonly co-expressed M1R and M3R muscarinic acetylcholine receptor subty...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mazen Tolaymat, Margaret H. Sundel, Madeline Alizadeh, Guofeng Xie, Jean-Pierre Raufman
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4ccf533168e34682a4486d0d353b67bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ccf533168e34682a4486d0d353b67bb
record_format dspace
spelling oai:doaj.org-article:4ccf533168e34682a4486d0d353b67bb2021-11-04T07:30:25ZPotential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases1663-981210.3389/fphar.2021.786105https://doaj.org/article/4ccf533168e34682a4486d0d353b67bb2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.786105/fullhttps://doaj.org/toc/1663-9812Despite structural similarity, the five subtypes comprising the cholinergic muscarinic family of G protein-coupled receptors regulate remarkably diverse biological functions. This mini review focuses on the closely related and commonly co-expressed M1R and M3R muscarinic acetylcholine receptor subtypes encoded respectively by CHRM1 and CHRM3. Activated M1R and M3R signal via Gq and downstream initiate phospholipid turnover, changes in cell calcium levels, and activation of protein kinases that alter gene transcription and ultimately cell function. The unexpectedly divergent effects of M1R and M3R activation, despite similar receptor structure, distribution, and signaling, are puzzling. To explore this conundrum, we focus on the gastrointestinal (GI) tract and liver because abundant data identify opposing effects of M1R and M3R activation on the progression of gastric, pancreatic, and colon cancer, and liver injury and fibrosis. Whereas M3R activation promotes GI neoplasia, M1R activation appears protective. In contrast, in murine liver injury models, M3R activation promotes and M1R activation mitigates liver fibrosis. We analyze these findings critically, consider their therapeutic implications, and review the pharmacology and availability for research and therapeutics of M1R and M3R-selective agonists and antagonists. We conclude by considering gaps in knowledge and other factors that hinder the application of these drugs and the development of new agents to treat GI and liver diseases.Mazen TolaymatMargaret H. SundelMadeline AlizadehGuofeng XieGuofeng XieGuofeng XieJean-Pierre RaufmanJean-Pierre RaufmanJean-Pierre RaufmanJean-Pierre RaufmanFrontiers Media S.A.articlemuscarinic receptorsG protein-coupled receptorsgastrointestinal physiologygastrointestinal diseaseliver diseasecancerTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic muscarinic receptors
G protein-coupled receptors
gastrointestinal physiology
gastrointestinal disease
liver disease
cancer
Therapeutics. Pharmacology
RM1-950
spellingShingle muscarinic receptors
G protein-coupled receptors
gastrointestinal physiology
gastrointestinal disease
liver disease
cancer
Therapeutics. Pharmacology
RM1-950
Mazen Tolaymat
Margaret H. Sundel
Madeline Alizadeh
Guofeng Xie
Guofeng Xie
Guofeng Xie
Jean-Pierre Raufman
Jean-Pierre Raufman
Jean-Pierre Raufman
Jean-Pierre Raufman
Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
description Despite structural similarity, the five subtypes comprising the cholinergic muscarinic family of G protein-coupled receptors regulate remarkably diverse biological functions. This mini review focuses on the closely related and commonly co-expressed M1R and M3R muscarinic acetylcholine receptor subtypes encoded respectively by CHRM1 and CHRM3. Activated M1R and M3R signal via Gq and downstream initiate phospholipid turnover, changes in cell calcium levels, and activation of protein kinases that alter gene transcription and ultimately cell function. The unexpectedly divergent effects of M1R and M3R activation, despite similar receptor structure, distribution, and signaling, are puzzling. To explore this conundrum, we focus on the gastrointestinal (GI) tract and liver because abundant data identify opposing effects of M1R and M3R activation on the progression of gastric, pancreatic, and colon cancer, and liver injury and fibrosis. Whereas M3R activation promotes GI neoplasia, M1R activation appears protective. In contrast, in murine liver injury models, M3R activation promotes and M1R activation mitigates liver fibrosis. We analyze these findings critically, consider their therapeutic implications, and review the pharmacology and availability for research and therapeutics of M1R and M3R-selective agonists and antagonists. We conclude by considering gaps in knowledge and other factors that hinder the application of these drugs and the development of new agents to treat GI and liver diseases.
format article
author Mazen Tolaymat
Margaret H. Sundel
Madeline Alizadeh
Guofeng Xie
Guofeng Xie
Guofeng Xie
Jean-Pierre Raufman
Jean-Pierre Raufman
Jean-Pierre Raufman
Jean-Pierre Raufman
author_facet Mazen Tolaymat
Margaret H. Sundel
Madeline Alizadeh
Guofeng Xie
Guofeng Xie
Guofeng Xie
Jean-Pierre Raufman
Jean-Pierre Raufman
Jean-Pierre Raufman
Jean-Pierre Raufman
author_sort Mazen Tolaymat
title Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
title_short Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
title_full Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
title_fullStr Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
title_full_unstemmed Potential Role for Combined Subtype-Selective Targeting of M1 and M3 Muscarinic Receptors in Gastrointestinal and Liver Diseases
title_sort potential role for combined subtype-selective targeting of m1 and m3 muscarinic receptors in gastrointestinal and liver diseases
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4ccf533168e34682a4486d0d353b67bb
work_keys_str_mv AT mazentolaymat potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT margarethsundel potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT madelinealizadeh potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT guofengxie potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT guofengxie potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT guofengxie potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT jeanpierreraufman potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT jeanpierreraufman potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT jeanpierreraufman potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
AT jeanpierreraufman potentialroleforcombinedsubtypeselectivetargetingofm1andm3muscarinicreceptorsingastrointestinalandliverdiseases
_version_ 1718445015638736896